Logo Logo Logo Logo Logo
  • Home
  • Focus & Investment process
  • About us
  • Partners
  • Portfolio
  • News
  • Vacancy
  • Contact
  • Home
  • Focus & Investment process
  • About us
  • Partners
  • Portfolio
  • News
  • Vacancy
  • Contact

23 Mar Our portfolio company Prolira – DeltaScan obtained FDA clearance for the DeltaScan Brain State Monitor

Posted at 09:32h in Uncategorized
Share

  UTRECHT, The Netherlands, March 15, 2023 – Prolira BV, a high-tech company committed...

Read More
Let’s Stay In Touch
Borski's updates

Borski Fund
Mauritskade 64
1092 AD Amsterdam
+31 (0) 205 682 085

 

info@borskifund.com

Links
  • Privacy statement
  • Borski Fund – Medium
  • FundrBird

© Copyright Borski Fund – Website made by aim

This website uses cookies. PrivacystatementAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT